TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22162538

Group type: EXPERIMENTAL
Intervention: HX575 (100 IU/kg)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Comparator epoetin alfa
Number of subjects: 149
Study: 20643827

Group type: EXPERIMENTAL
Intervention: Selenium-enriched yeast (SY) supplementation (247 microg/d)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (nonenriched yeast)
Number of subjects: 36
Study: 18984650

Group type: EXPERIMENTAL
Intervention: Montelukast 4 mg sachets, daily from hospital admission until discharge
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo, daily from hospital admission until discharge
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Montelukast 4 mg sachets
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 15642753

Group type: EXPERIMENTAL
Intervention: Nurse home visiting asthma education program (8 lessons)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Nurse home visiting asthma education program
Number of subjects: 55
Study: 12842372

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 383

Group type: COMPARATOR
Intervention: Hepatitis A or B vaccines
Number of subjects: 383
Study: 10999260

Group type: EXPERIMENTAL
Intervention: Focusing on the ball leaving the racket (effect) during tennis ball hitting
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Focusing on the club (technique-related effect) during golf ball hitting
Number of subjects: 2

Group type: COMPARATOR
Intervention: Focusing on the ball coming toward them (antecedent) during tennis ball hitting
Number of subjects: 2

Group type: COMPARATOR
Intervention: Focusing on the ball trajectory (outcome) during golf ball hitting
Number of subjects: 2
Study: 8838484

Group type: COMPARATOR
Intervention: 75 micrograms gestodene + 30 micrograms ethinyl estradiol (EE)
Number of subjects: 2767

Group type: EXPERIMENTAL
Intervention: 150 micrograms desogestrel + 30 micrograms ethinyl estradiol (EE)
Number of subjects: 2767

Group type: EXPERIMENTAL
Intervention: 150 micrograms desogestrel + 20 micrograms ethinyl estradiol (EE)
Number of subjects: 2767

Group type: EXPERIMENTAL
Intervention: Desogestrel-containing preparation
Number of subjects: 2767
Study: 1299421

Group type: EXPERIMENTAL
Intervention: alpha‐2a Interferon (IFN) (100,000 I.U. in 1 ml)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 13
Study: 6493939

Group type: EXPERIMENTAL
Intervention: Self-observation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paradoxical Intention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rational Self-statement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expectancy Control
Number of subjects: 0
Study: 30893236

Group type: EXPERIMENTAL
Intervention: Risk calculator incorporating 17 predictive variables for 90-day readmission after TJA
Number of subjects: 10155
Study: 29286542

Group type: EXPERIMENTAL
Intervention: abstinence initiators (n=17)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: already abstainers (n=20)
Number of subjects: 78

Group type: COMPARATOR
Intervention: continued drinkers (n=41)
Number of subjects: 78
Study: 27881523

Group type: EXPERIMENTAL
Intervention: Culture-sensitive adapted material
Number of subjects: 435

Group type: COMPARATOR
Intervention: Standard translated material
Number of subjects: 435
Study: 24465565

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (H, midway between LT and VO2peak, 30 min)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (M, @ lactate threshold (LT), 30 min)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (C, no exercise)
Number of subjects: 26
Study: 22282154

Group type: EXPERIMENTAL
Intervention: Tailored nursing intervention (one nurse‐patient meeting before discharge with 2 additional contacts over 10 days, mean duration = 40 minutes per contact)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Tailored nursing intervention
Number of subjects: 242

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 242
Study: 20227053

Group type: EXPERIMENTAL
Intervention: Rescue antenatal steroids
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 17598898

Group type: EXPERIMENTAL
Intervention: Mild induced hypothermia (MIH)
Number of subjects: 40
Study: 16127467

Group type: EXPERIMENTAL
Intervention: Prototype Deep Clean manual toothbrush
Number of subjects: 60

Group type: COMPARATOR
Intervention: ADA manual toothbrush plus floss
Number of subjects: 60

Group type: COMPARATOR
Intervention: ADA manual toothbrush alone
Number of subjects: 60
Study: 12352079

Group type: EXPERIMENTAL
Intervention: Nonmechanical trephination
Number of subjects: 184

Group type: COMPARATOR
Intervention: Mechanical trephination
Number of subjects: 184
Study: 10520054

Group type: EXPERIMENTAL
Intervention: Active allergen-avoidance measures (Acarosan(R) and HDM-impermeable covers)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo allergen-avoidance measures (water and cotton covers)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Active allergen-avoidance measures
Number of subjects: 157
Study: 7796587

Group type: EXPERIMENTAL
Intervention: Oral contraceptive containing 30 mcg ethinylestradiol and 150 mcg desogestrel
Number of subjects: 783

Group type: COMPARATOR
Intervention: Oral contraceptive containing 30 mcg ethinylestradiol and 75 mcg gestodene
Number of subjects: 783
Study: 2442560

Group type: EXPERIMENTAL
Intervention: Lisinopril 5 mg daily (with option to increase to 10 or 20 mg)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 31912141

Group type: EXPERIMENTAL
Intervention: 1:1 packed red blood cell to fresh frozen plasma transfusion ratio
Number of subjects: 68

Group type: COMPARATOR
Intervention: 4:1 packed red blood cell to fresh frozen plasma transfusion ratio
Number of subjects: 68
Study: 28965070

Group type: EXPERIMENTAL
Intervention: 10-min mindfulness exercise
Number of subjects: 86
Study: 27484334

Group type: EXPERIMENTAL
Intervention: Platelet transfusion within 6 hours of symptom onset and 90 minutes of diagnostic brain imaging
Number of subjects: 190

Group type: COMPARATOR
Intervention: Standard care without platelet transfusion
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Platelet transfusion
Number of subjects: 190
Study: 24430095

Group type: EXPERIMENTAL
Intervention: Reprogramming of existing pacemakers to reduce RV pacing
Number of subjects: 66
Study: 23385792

Group type: EXPERIMENTAL
Intervention: Lutein supplementation (10 mg Ester daily)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Lutein supplementation (10 mg Ester daily) in subgroup (n = 19)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo in subgroup (n = 14)
Number of subjects: 72
Study: 20435266

Group type: EXPERIMENTAL
Intervention: Quantitative ultrasound parameters (QUS) including amplitude‐dependent speed of sound (AD‐SoS), bone transmission time (BTT), US peak amplitude (UPA), signal dynamic (SDY), slope, energy, and fast wave amplitude (FWA)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Quantitative ultrasound parameters (AD‐SoS, UPA, SDY, slope, energy)
Number of subjects: 101
Study: 18250965

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) plus concomitant and adjuvant temozolomide
Number of subjects: 32
Study: 19077388

Group type: EXPERIMENTAL
Intervention: 20 mg oral pyridoxine thrice daily
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 15793163

Group type: EXPERIMENTAL
Intervention: procainamide plus levofloxacin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: procainamide plus ciprofloxacin
Number of subjects: 10

Group type: COMPARATOR
Intervention: procainamide only
Number of subjects: 10
Study: 16148965

Group type: COMPARATOR
Intervention: Treatment group received the 2000 version of the Medicare & You handbook; control group received no Medicare-related information.
Number of subjects: 3738

Group type: COMPARATOR
Intervention: Re-mail group received a second copy of the handbook along with their mail survey instrument; no significant differences noted.
Number of subjects: 3738
Study: 9210742

Group type: EXPERIMENTAL
Intervention: Happiness
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sadness
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Disgust
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control conditions (film and recall)
Number of subjects: 12
Study: 8359565

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of Sandostatin (SMS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Oesophageal tamponade (OT)
Number of subjects: 16
Study: 2444797

Group type: EXPERIMENTAL
Intervention: Felodipine (10 mg single dose)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Felodipine (10 mg twice daily for 8 weeks)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 11456286

Group type: EXPERIMENTAL
Intervention: Gliclazide 160 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31491428

Group type: EXPERIMENTAL
Intervention: Shorter telomere length at follow-up (p=0.044)
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Greater telomere attrition during follow-up (p=0.022)
Number of subjects: 1035

Group type: COMPARATOR
Intervention: No similar associations found for men
Number of subjects: 1035
Study: 30208070

Group type: EXPERIMENTAL
Intervention: Maintenance Care (MC)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Symptom-guided treatment (Control)
Number of subjects: 328
Study: 27721545

Group type: EXPERIMENTAL
Intervention: Three options MCQ test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Four options MCQ test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Five options MCQ test
Number of subjects: 0
Study: 24797121

Group type: EXPERIMENTAL
Intervention: Low-dose opioid regimen (remifentanil effect-site concentration half of propofol)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: High-dose opioid regimen (remifentanil effect-site concentration double that of propofol)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no words played during anesthesia)
Number of subjects: 120
Study: 22932261

Group type: EXPERIMENTAL
Intervention: Health education intervention (45-minute conference-style training)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group (no health education)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Health education intervention
Number of subjects: 148
Study: 20530294

Group type: COMPARATOR
Intervention: Control (bed rest without exercise)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resistive exercise
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise
Number of subjects: 18
Study: 17634269

Group type: EXPERIMENTAL
Intervention: Medox (anthocyanin supplementation, 300 mg/d for 3 weeks)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 16334439

Group type: EXPERIMENTAL
Intervention: Metronidazole (5 days)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Metronidazole (5 days) + Oligofructose (12 days)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oligofructose (12 days)
Number of subjects: 16
Study: 12498337

Group type: EXPERIMENTAL
Intervention: Stimulant medication
Number of subjects: 18
Study: 9811916

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 2226

Group type: COMPARATOR
Intervention: Medical care
Number of subjects: 2226
Study: 7665416

Group type: EXPERIMENTAL
Intervention: Added fat and protein (FP) diet (C diet + 1.6 g.kg‐1.day‐1 fat + 1.2 g.kg‐1.day‐1 protein)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (C) diet (high glycemic index CHO foods; CHO = 7 g.kg‐1.day‐1)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Matched-energy diet (C diet + 4.8 g.kg‐1.day‐1 additional CHO)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Added fat and protein (FP) diet
Number of subjects: 8
Study: 2550243

Group type: EXPERIMENTAL
Intervention: Isradipine (IS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 18
Study: 1103333

Group type: EXPERIMENTAL
Intervention: Adriamycin
Number of subjects: 39

Group type: COMPARATOR
Intervention: Melphalan
Number of subjects: 39
Study: 31282686

Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (psychosocial stress induction)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo version (active control)
Number of subjects: 122
Study: 29183931

Group type: EXPERIMENTAL
Intervention: Early low-energy enteral nutrition (10 kcal/kg/day)
Number of subjects: 220

Group type: COMPARATOR
Intervention: High-energy enteral nutrition (25 kcal/kg/day)
Number of subjects: 220
Study: 25203688

Group type: EXPERIMENTAL
Intervention: 39 g·hr(‐1) carbohydrate (CHO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 64 g·hr(‐1) carbohydrate (CHO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 20 g·hr(‐1) carbohydrate (CHO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0 g·hr(‐1) control (water)
Number of subjects: 20
Study: 24687355

Group type: EXPERIMENTAL
Intervention: Infant formula added with a dual prebiotic system 'Metlin® and Metlos®' from Mexican agave
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard infant formula (control)
Number of subjects: 600
Study: 21281959

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 19097848

Group type: COMPARATOR
Intervention: 10-day antibiotic therapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 7-day antibiotic therapy
Number of subjects: 30
Study: 16651505

Group type: EXPERIMENTAL
Intervention: Pilot studies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 12590356

Group type: EXPERIMENTAL
Intervention: Risperidone 2-6 mg/day
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Olanzapine 5-20 mg/day
Number of subjects: 377
Study: 10565798

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Amitriptyline (50-250 mg/day, mean 138.1 mg/day)
Number of subjects: 157
Study: 8908893

Group type: EXPERIMENTAL
Intervention: Mailed postcard reminders
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (no postcard reminders)
Number of subjects: 107
Study: 1833917

Group type: EXPERIMENTAL
Intervention: Steam sterilization
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Lyophilization
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Lyophilization + gamma irradiation
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Lyophilization + gamma irradiation in argon
Number of subjects: 200

Group type: COMPARATOR
Intervention: ‐25 degrees C deep freezing (control group)
Number of subjects: 200
Study: 6136695

Group type: EXPERIMENTAL
Intervention: Combination cytotoxic chemotherapy (intravenous cyclophosphamide, methotrexate, and fluorouracil)
Number of subjects: 368

Group type: COMPARATOR
Intervention: No chemotherapy or conventionally timed chemotherapy
Number of subjects: 368
Study: 31493951

Group type: EXPERIMENTAL
Intervention: AdtFMD vaccine (commercial vaccine vector expressing capsid proteins of FMDV strain A24 Cruzeiro)
Number of subjects: 0
Study: 27481104

Group type: EXPERIMENTAL
Intervention: Personalized exercise prescription (intensity that 'feels good' to the individual for 8 weeks during daily Physical Education)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate-intensity exercise prescription (target heart rate range 60-80% of HR max for 8 weeks during daily Physical Education)
Number of subjects: 0
Study: 26838998

Group type: EXPERIMENTAL
Intervention: Exercise and fall prevention self-management intervention (individualised exercise program with motivational interviewing, plus fall prevention education through individualised advice or group-based 'Stepping On' program).
Number of subjects: 350

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Exercise and fall prevention self-management intervention.
Number of subjects: 350
Study: 24134709

Group type: EXPERIMENTAL
Intervention: Intensive self-help version of 'Balance', online multi-session follow-up program
Number of subjects: 244

Group type: COMPARATOR
Intervention: Brief self-help version of 'Balance', online single session screening procedure
Number of subjects: 244
Study: 22495590

Group type: EXPERIMENTAL
Intervention: Sympathetic inhibition via clonidine (48 h transdermal administration) during hypoxia
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hypoxia (FIO₂ =0.11)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normoxia (FIO₂ =0.21)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normoxia and sympathetic inhibition
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypoxia and sympathetic inhibition
Number of subjects: 10
Study: 19615155

Group type: EXPERIMENTAL
Intervention: 13C-methacetin breath test (13C-MBT)
Number of subjects: 69
Study: 17445031

Group type: EXPERIMENTAL
Intervention: Hindmilk feeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Composite breast milk feeding (Control)
Number of subjects: 0
Study: 15823786

Group type: EXPERIMENTAL
Intervention: Mediterranean Lifestyle Program
Number of subjects: 279
Study: 12452301

Group type: EXPERIMENTAL
Intervention: Enoxaparin (1 mg/kg twice daily by SC injection)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Dalteparin (120 IU/kg twice daily by SC injection)
Number of subjects: 142
Study: 9607384

Group type: EXPERIMENTAL
Intervention: 10 mg tasosartan
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: 30 mg tasosartan
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: 100 mg tasosartan
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: 300 mg tasosartan
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: All tasosartan dosages
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study: 8169569

Group type: EXPERIMENTAL
Intervention: Active marijuana cigarettes (2.3% delta 9-THC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Marijuana cigarettes with varying tetrahydrocannabinol content (0.0%, 2.0%, and 3.5%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choice between previously sampled doses (0.0%, 2.0%, and 3.5%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Marijuana cigarettes with varying tetrahydrocannabinol content
Number of subjects: 0
Study: 2899108

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Time of shaving the operation site
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Type of theatre ventilation
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Duration of operation
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Season
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Age of patient
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Sex of patient
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Carriage of Staphylococcus aureus
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Airborne bacterial count
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Presence of bacteria in the wound
Number of subjects: 536
Study: 31753745

Group type: EXPERIMENTAL
Intervention: Post-operative compression (compression stockings continuously for two days, then during the daytime for five days)
Number of subjects: 177

Group type: COMPARATOR
Intervention: No compression
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Post-operative compression
Number of subjects: 177
Study: 31497988

Group type: COMPARATOR
Intervention: Oral alcohol administration (exact dosage not specified)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Oral alcohol administration
Number of subjects: 260
Study: 28064029

Group type: EXPERIMENTAL
Intervention: Statistical methods for adjusting for baseline variables (specific methods not detailed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardization methods from recent statistics literature
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Software in R and Stata for implementing statistical methods
Number of subjects: 0
Study: 25526758

Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 13

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 13
Study: 23512773

Group type: EXPERIMENTAL
Intervention: Intragastric balloon (IGB) for 6 months with 12 month behavioral modification
Number of subjects: 66

Group type: COMPARATOR
Intervention: Behavioral modification alone (Control Group)
Number of subjects: 66
Study: 21418261

Group type: EXPERIMENTAL
Intervention: Bifidobacterium bifidum MIMBb75
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 19648776

Group type: EXPERIMENTAL
Intervention: 5% dexpanthenol ointment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo ointment (vehicle without dexpanthenol)
Number of subjects: 18
Study: 17918695

Group type: EXPERIMENTAL
Intervention: TB3 (Thera-Band training three times/week)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TB5 (Thera-Band training five times/week)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CON (Control group)
Number of subjects: 30
Study: 15168433

Group type: EXPERIMENTAL
Intervention: Participants with close friends from the target group
Number of subjects: 2

Group type: COMPARATOR
Intervention: Participants without close friends from the target group
Number of subjects: 2
Study: 11379804

Group type: EXPERIMENTAL
Intervention: Intranasal IL-6 (0, 0.01, 0.1, and 1 microg/mL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 30
Study: 9224439

Group type: EXPERIMENTAL
Intervention: Behavioral treatment emphasizing patient pleasant events
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Behavioral treatment emphasizing caregiver problem solving
Number of subjects: 72

Group type: COMPARATOR
Intervention: Typical care condition
Number of subjects: 72

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 72
Study: 8128463

Group type: EXPERIMENTAL
Intervention: Bubble oxygenation without an arterial line filter (Group I, n = 17)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Bubble oxygenation with an arterial filter (Group II, n = 17)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Membrane oxygenation without an arterial filter (Group III, n = 20)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Membrane oxygenator group
Number of subjects: 54